MYC and familial pancreatic carcinoma: However, as far as we know, this study shows for the first time that c-Myc, through the activation of the mevalonate pathway, sustains mutp53 expression level in pancreatic cancer cells, giving back to this oncosuppressor—becoming an oncogene—the favor to be transactivated by it.